The Numb paradox: one protein, multiple isoforms, opposing functions in neurodevelopment, endocytic trafficking, and cancer

Numb is a multifunctional adaptor protein that serves as a central regulator of cell fate, linking polarity, signaling, and endocytic trafficking from early development to disease. Initially discovered in Drosophila melanogaster as an intrinsic determinant of asymmetric cell division, Numb's antagonism of Notch signaling has proven to be evolutionarily conserved in mammals, orchestrating the balance between progenitor maintenance and differentiation during neurogenesis. In the mammalian brain, Numb and its paralog, Numb-like (Numbl), integrate polarity cues, receptor trafficking, and transcriptional networks to guide cortical development and maintain neural stem cell homeostasis. Alternative splicing generates multiple Numb isoforms (i.e., p72, p71, p66, and p65) that exhibit distinct structural and functional properties, allowing context-dependent modulation of Notch, p53, and integrin pathways. Isoform-specific expression patterns underlie divergent roles in neurodevelopment, neurite morphogenesis, and tumorigenesis, whereby Numb can act either as a tumor suppressor or as an oncogenic driver. Dysregulated splicing, posttranslational modification, and interaction with RNA-binding proteins such as RBM4, PTBP1, or SRSF9 reprogram Numb's activity across developmental and cancer contexts. Emerging evidence also connects Numb isoform regulation to neurodegenerative processes, including tauopathies and viral neuropathogenesis, as observed in Zika virus infection. Collectively, these findings position Numb as a molecular switch at the crossroads of neurodevelopment, cancer, and degeneration with its isoform diversity providing both mechanistic insight and therapeutic potential for restoring differentiation, restraining oncogenesis, and protecting neuronal integrity.